Betamethasone Dipropionate USP, 0.05%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Betamethasone Dipropionate USP, 0.05%, covering 2022-02-18 to 2022-02-18. Get the full timeline:
Most recent: FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)